<i>Quo vadis</i> (where are you going) pharmacovigilance?

Kulkarni, Spoorthy; Rieder, Michael J.; Likić, Robert

doi:10.1111/bcp.15584

Cited by 1 publication

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this study, we sought to describe the publication trends and characteristics of pharmacovigilance-related research stemming out of Africa in comparison to that from developed countries. This study indicates that pharmacovigilance literature output is steadily increasing annually in keeping with trends observed for public health research output from Africa [20] and global trends [21,22], but at a slower rate compared to Europe. Most of the African pharmacovigilance research output is funded by European and American funders through international public health initiatives.…”

Section: Discussionsupporting

confidence: 76%

“…Thirdly, raising PV awareness through public engagement and increasing healthcare practitioner PV education during basic professional training may increase the reach and extent of the discipline [ 26 ]. Lastly, the adoption of electronic health information systems and artificial intelligence together with the implementation of joint, regional pharmacovigilance programs could potentially improve and sustain the continent’s pharmacovigilance practices [ 22 , 27 , 28 ].…”

Section: Reviewmentioning

confidence: 99%

See 1 more Smart Citation

An Exploratory Bibliometric Analysis of African Pharmacovigilance Research Output Using SCOPUS

Masuka

2024

Cureus

View full text Add to dashboard Cite

Most global pharmacovigilance (PV) data is derived from developed countries. However, the determinants of the differences in PV research output between developing and developed countries contributing to this discrepancy still need to be explored. The objective of the current study is to describe the publication trends and characteristics of pharmacovigilance-related research stemming out of Africa in comparison to that emanating from developed countries. A bibliometric analysis was carried out using the SCOPUS literature index for published global pharmacovigilance-related articles or documents pre-COVID-19. Data on annual publication trends, citations, author affiliations, and other study characteristics such as study funding were extracted and descriptively analyzed. Author co-citation and keyword co-occurrence analyses were also conducted and presented using VOSviewer software program version 1.6.15 (CWTS, Universiteit Leiden, Netherlands). During the period under review, a total of 27,516 documents were retrieved globally. Out of these, 588 (2.1 %), 9,438 (34.3 %), and 17,829 (64.8 %) were from Africa, Europe, and the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) founder member countries respectively. Annual publications have steadily increased, but at a slower rate in Africa compared to Europe. The mean annual publications and number of citations are significantly lower in Africa compared to Europe, p < 0.0001 for both parameters. The top 10 funders of African PV activities are European and American organizations. In conclusion, improved PV activity driven by international funders has been notable on the African continent. However, there is an increased need for local funding, government involvement, and legislation to improve PV activities on the African continent.

show abstract

Section: Discussionsupporting

confidence: 76%